Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand

PHASE4CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Pertussis
Interventions
BIOLOGICAL

Boostrix

Pregnant women will be vaccinated with an acellular pertussis containing vaccine between 27 and 36 weeks of gestation.

BIOLOGICAL

Infanrix hexa

Children from group A will be vaccinated with an acellular pertussis containing vaccine according to the official recommendations in Thailand at 2, 4, 6 and 18 months.

BIOLOGICAL

Quinvaxem

Children from group B will be vaccinated with a whole cell pertussis containing vaccine according to the official recommendations in Thailand at 2, 4, 6 and 18 months.

BIOLOGICAL

OPV

Children from group B will be vaccinated with OPV vaccine according to the official recommendations in Thailand at 2, 4, 6 and 18 months.

Trial Locations (1)

10330

Chulalongkorn University, Bangkok

All Listed Sponsors
collaborator

Chulalongkorn University

OTHER

collaborator

Institut Pasteur de Lille

OTHER

collaborator

Thrasher Research Fund

OTHER

lead

Universiteit Antwerpen

OTHER

NCT02408926 - Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand | Biotech Hunter | Biotech Hunter